New pill could cut heart failure deaths when given early in hospital

NCT ID NCT07397650

First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This study tests whether starting the drug finerenone early during a hospital stay for acute heart failure can improve outcomes. About 550 adults with heart failure and preserved ejection fraction will receive either finerenone or a placebo. Researchers will track deaths, worsening heart failure, and symptom changes over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Finerenone oral tablet
What this could lead to
If successful, this could show that starting finerenone early in the hospital reduces death and worsening heart failure events after discharge.
What could go wrong
This is a phase 4 trial, but heart failure is complex and results may not apply to all patients. The benefit may be modest or not statistically significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chita Peninsula General Medical Center

    RECRUITING

    Handa, Aichi-ken, Japan

  • Chutoen General Medical Center

    RECRUITING

    Kakegawa, Shizuoka, Japan

  • Ehime University Hospital

    RECRUITING

    Tōon, Ehime, Japan

  • Gunma Prefectural Cardiovascular Center

    NOT_YET_RECRUITING

    Maebashi, Gunma, Japan

  • Gunma University Hospital

    RECRUITING

    Maebashi, Gunma, Japan

  • Hokkaido Cardiovascular Hospital

    RECRUITING

    Sapporo, Hokkaido, Japan

  • Iizuka Hospital

    RECRUITING

    Iizuka, Fukuoka, Japan

  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital

    NOT_YET_RECRUITING

    Nagoya, Aichi-ken, Japan

  • Japanese Red Cross Fukuoka Hospital

    NOT_YET_RECRUITING

    Fukuoka, Fukuoka, Japan

  • Juntendo University Hospital

    RECRUITING

    Tokyo, Japan

  • Juntendo University Shizuoka Hospital

    NOT_YET_RECRUITING

    Izunokuni, Shizuoka, Japan

  • Kindai University Hospital

    RECRUITING

    Sakai, Osaka, Japan

  • Kitasato University Hospital

    NOT_YET_RECRUITING

    Sagamihara, Kanagawa, Japan

  • NHO Takasaki General Medical Center

    RECRUITING

    Takasaki, Gunma, Japan

  • Nagoya University Hospital

    RECRUITING

    Nagoya, Aichi-ken, Japan

  • National Center for Geriatrics and Gerontology

    NOT_YET_RECRUITING

    Ōbu, Aichi-ken, Japan

  • National Cerebral and Cardiovascular Center

    NOT_YET_RECRUITING

    Suita, Osaka, Japan

  • Osaka General Medical Center

    RECRUITING

    Osaka, Japan

  • Saitama Medical Center

    NOT_YET_RECRUITING

    Kawagoe, Saitama, Japan

  • The University of Osaka Hospital

    RECRUITING

    Suita, Osaka, Japan

  • Toyota Kosei Hospital

    RECRUITING

    Toyota, Aichi-ken, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.